癌症化学抵抗中的KLF4:分子机制和治疗影响
Suresh Singh Yadav1, Punita Kalia2, Navneet Kaur2
1Department of Molecular Biology and Biochemistry, Guru Nanak Dev University, Amritsar, Punjab, 143005, India. suresh4bhu@gmail.com.
Discover oncology
|September 22, 2025
概括
化学抵抗仍然是癌症治疗中的一个重大障碍. 本综述强调了克鲁佩尔样因子4 (KLF4) 作为药物耐药机制的关键调节者,提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 化学抵抗是导致癌症治疗失败和疾病进展的主要原因.
- 转录因子克鲁佩尔样因子4 (KLF4) 越来越多地被认为在癌症中的作用.
- 了解KLF4的功能对于克服治疗阻力至关重要.
研究的目的:
- 审查KLF4在调解癌症化学抵抗中的多方面的作用.
- 阐明KLF4对药物耐药性的分子机制.
- 探索针对KLF4驱动化学抵抗的潜在治疗策略.
主要方法:
- 对研究KLF4在癌症化学抵抗中的研究的文献综述.
- 分析KLF4参与药物流量,DNA修复,细胞亡和干性.
- 在不同类型的癌症中检查KLF4翻译后修饰 (PTMs).
主要成果:
- KLF4调节关键过程,包括药物排放,DNA修复,亡信号传递,瘤异质性和癌症干细胞性.
- 组织特异性KLF4的翻译后修改显著影响化学抵抗.
- KLF4集成了多种不同的信号通路,以促进耐药的表型.
结论:
- 通过各种细胞机制,KLF4是化学抵抗的关键决定因素.
- 针对KLF4及其监管网络是克服治疗耐药性的有希望的策略.
- 对KLF4介导的耐药机制的进一步研究可以导致更有效的癌症疗法.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Adaptive Mechanisms in Cancer Cells
6.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


